Our study also showed a trend toward better DFS in patients with any CTAs positive for MAGE-A4, NY-ESO-1, KK-LC-1 and PRAME.
← all excerpts
Expression of four cancer-testis antigens in TNBC indicating potential universal immunotherapeutic targets.
1
—
—